LS
Lin Shen

Publications (13)

Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
Article scientifique · 2019
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study
Article scientifique · 2019
MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: a patient-based multi-parameter study
Article scientifique · 2018
Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance
Article scientifique · 2018
A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer
Article scientifique · 2018
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
Article scientifique · 2018
Author Correction: A proteomic landscape of diffuse-type gastric cancer
Article scientifique · 2018
Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
Article scientifique · 2018
Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
Article scientifique · 2018
Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
Article scientifique · 2018
Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
Article scientifique · 2017
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Article scientifique · 2017
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
Article scientifique · 2017

Domaines principaux

Sciences de la santé9 Sciences de la vie et biotechnologies4

Statistiques

Consultations24
Téléchargements0